Biologically Active Arg-Gly-Asp Oligopeptides Assume a Type II β-Turn in Solution

W. Curtis Johnson, Thomas G. Pagano, Craig Todd Basson, Joseph A. Madrid, Paul Gooley, Ian M. Armitage

Research output: Contribution to journalArticlepeer-review

63 Scopus citations


The sequence Arg-Gly-Asp (RGD) has been found to be the consensus sequence of matrix proteins for binding cell surface receptors (integrins). Studies with synthetic peptides containing the RGD sequence show that the biological activity of these oligopeptides is removed upon a conservative substitution of Glu for Asp in the RGD sequence. Two-dimensional NMR methods were used to investigate the secondary structures in aqueous solution for two such oligopeptides of differing biological activity. The sequence Tyr-Gly-Arg-Gly-Asp-Ser-Pro, which binds to selected integrins, is found to assume a type II (β-turn at both pH 4 and 7. In contrast, the sequence Tyr-Gly-Arg-Gly-Glu-Ser-Pro, which does not interfere with integrin-mediated cell attachment, is found to assume a type I or III β-turn at both pH 4 and 7. This comparison confirms not only that oligopeptides can assume a secondary structure in aqueous solution, but also that these structures may be important to biological functions.

Original languageEnglish (US)
Pages (from-to)268-273
Number of pages6
Issue number1
StatePublished - Jan 1 1993


Dive into the research topics of 'Biologically Active Arg-Gly-Asp Oligopeptides Assume a Type II β-Turn in Solution'. Together they form a unique fingerprint.

Cite this